Page last updated: 2024-08-25

methotrexate and Neuroectodermal Tumors

methotrexate has been researched along with Neuroectodermal Tumors in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Adhikari, N; Bakhshi, S; Biswas, A; Khanna, G; Suri, V1
Bamberg, M; Dieckmann, K; Kortmann, RD; Kühl, J; Meisner, C; Pietsch, T; Timmermann, B1

Trials

1 trial(s) available for methotrexate and Neuroectodermal Tumors

ArticleYear
Role of radiotherapy in the treatment of supratentorial primitive neuroectodermal tumors in childhood: results of the prospective German brain tumor trials HIT 88/89 and 91.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2002, Feb-01, Volume: 20, Issue:3

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cytarabine; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Lomustine; Male; Methotrexate; Neoplasm Recurrence, Local; Neuroectodermal Tumors; Radiotherapy Dosage; Supratentorial Neoplasms; Survival Rate; Treatment Outcome; Vincristine

2002

Other Studies

1 other study(ies) available for methotrexate and Neuroectodermal Tumors

ArticleYear
A rare case of paediatric primary central nervous system lymphoma treated with high-dose methotrexate and rituximab-based chemoimmunotherapy and whole brain radiotherapy followed by tumour bed boost with three-dimensional conformal radiation technique.
    Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery, 2018, Volume: 34, Issue:9

    Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Immunological; Brain Neoplasms; Chemoradiotherapy; Child; Cranial Irradiation; Female; Follow-Up Studies; Humans; Imaging, Three-Dimensional; Immunotherapy; Lymphoma, B-Cell; Male; Methotrexate; Neuroectodermal Tumors; Rituximab

2018